polymer-chemistry
(3)
Polymateria
Polymateria is a London-based materials science company that has developed Biotransformation, a masterbatch additive that lets everyday polyolefin plastics fully biodegrade in the open environment within about a year - breaking down into a wax that microbes consume, leaving only CO2, water and biomass with no microplastics. Its technology underpins the BSI PAS 9017 standard and is sold to converters and brands worldwide through its consumer-facing Lyfecycle brand.
Myris Therapeutics
Myris Therapeutics is a Pittsburgh-based precision oncology company building the next generation of antibody drug conjugates (ADCs). Formerly BioHybrid Solutions, Myris uses proprietary polymer chemistry rooted in Carnegie Mellon's ATRP (atom transfer radical polymerization) technology to grow polymer bottlebrushes on antibodies, achieving ultra-high drug-to-antibody ratios (DAR) of 50-300 - roughly 10 to 100 times higher than conventional ADCs. That capability opens up new chemical space for cancer payloads that were previously unusable, aiming to deliver more potent, precisely targeted therapies.
Laura E. Benjamin
Laura E. Benjamin is the CEO and President of Myris Therapeutics, a Pittsburgh-based biotech building ultra-high DAR antibody-drug conjugates that fuse polymer chemistry with cancer biologics. A molecular biologist by training, she has moved from Harvard pathology labs to Eli Lilly oncology leadership to two CEO chairs - most recently steering OncXerna through more than $100 million in clinical-stage financing before taking the helm at Myris in 2024.